Perimeter Medical Imaging AI, Inc.

Industry
Medical Technology
Founded Year
2013
Headquarters
Dallas, Texas, USA
Employee Count
71

Key People

Assessment

Team
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced executives with backgrounds in medical technology and commercialization.

The CEO, Adrian Mendes, has a strong background in scaling technology companies, and the VP of Sales and Marketing, Adam Hodges, brings over 20 years of commercialization experience in the medical device industry.

Clinical Need
Aspect: Very Strong
Summary: The company's imaging solutions address significant unmet needs in cancer surgery.

Perimeter's FDA-cleared S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level, addressing the critical need for accurate margin assessment during cancer surgeries.

Competition
Aspect: First mover
Summary: Perimeter appears to be a pioneer in integrating OCT imaging with AI for intraoperative use.

While other companies offer intraoperative imaging solutions, Perimeter's combination of OCT technology with AI assistance is unique, potentially setting it apart in the market.

Technical Challenge
Aspect: Moderate
Summary: Developing and integrating AI with OCT imaging presents moderate technical challenges.

While OCT imaging is established, integrating AI for real-time analysis requires overcoming challenges related to data processing, accuracy, and regulatory approval.

Patent
Aspect: Strong
Summary: The company holds strong patents protecting its technology.

Perimeter's patents cover key aspects of its imaging technology, potentially preventing competitors from developing similar solutions.

Financing
Aspect: Well-funded
Summary: The company has secured significant funding, including grants and investments.

Perimeter received a grant of up to $7.4 million from the Cancer Prevention and Research Institute of Texas and has backing from investors like Social Capital.

Regulatory
Aspect: 510k/PMA
Summary: The company has obtained FDA clearance for its S-Series OCT system.

FDA clearance indicates that the product meets safety and efficacy standards, allowing for commercialization in the U.S. market.

Opportunity Rollup

Odds of Success
4.3
Peak Market Share
6.05
Segment CAGR
2.9%
Market Segment
Diagnostic Imaging
Market Sub Segment
Intraoperative Imaging
Year Post Launch Market Penetration (%)
1 0.30
2 0.91
3 2.12
4 4.24
5 6.05

Key Takeaway

Perimeter Medical Imaging AI, Inc. is well-positioned to capitalize on the growing demand for precision surgical tools, leveraging its innovative OCT and AI technologies to improve cancer surgery outcomes.